Chewy(CHWY)
Search documents
Chewy(CHWY) - 2024 Q1 - Quarterly Report
2023-05-30 16:00
Financial Performance - Net sales for the thirteen weeks ended April 30, 2023, were $2,784,675, an increase of $356,348 or 14.7% compared to $2,428,327 for the same period in 2022[146]. - Gross profit for the same period increased by $123.6 million, or 18.5%, to $791.5 million, with gross profit as a percentage of net sales rising by 90 basis points[147]. - Net income for the thirteen weeks ended April 30, 2023, was $22,181, compared to $18,472 for the same period in 2022[184]. - The Company reported earnings attributable to common Class A and Class B stockholders of $22.181 million for the 13 weeks ended April 30, 2023, compared to $18.472 million for the same period in 2022, representing a year-over-year increase of approximately 20.5%[190]. - Basic earnings per share increased to $0.05 for the 13 weeks ended April 30, 2023, up from $0.04 for the same period in 2022, reflecting a 25% increase[190]. - Adjusted EBITDA reached $110,174, up 82.1% from $60,516 in the previous year, with an adjusted EBITDA margin of 4.0%[251]. - Net income for the same period was $22,181, a 20.1% increase from $18,472 in the prior year[251]. Cash Flow and Liquidity - Net cash provided by operating activities was $148,392 for the thirteen weeks ended April 30, 2023, compared to $82,433 for the same period in 2022[151]. - Free cash flow for the period was $126,819, significantly up from $6,412 in the previous year[251]. - The company maintains sufficient liquidity with cash and cash equivalents, marketable securities, and availability under its revolving credit facility for at least the next twelve months[150]. - Net cash used in investing activities was $66,038 for the thirteen weeks ended April 30, 2023, primarily for marketable securities and capital expenditures[153]. Sales and Customer Metrics - The company reported an increase in consumables sales by $306,245 or 18.0% to $2,004,384 for the thirteen weeks ended April 30, 2023[146]. - Autoship customer sales increased to $2,080,510, an 18.6% rise from $1,753,681 in the same period last year[251]. - Active customers decreased slightly to 20,419 from 20,601, reflecting a 0.9% decline[251]. Expenses and Costs - Selling, general, and administrative expenses for the period were $583,666, up from $504,283 in the prior year[184]. - Share-based compensation expense totaled $48,553, compared to $25,794 in the prior year[242]. - The Company recorded depreciation expense on property and equipment of $21.3 million for the 13 weeks ended April 30, 2023, compared to $12.1 million for the same period in 2022, indicating an increase of approximately 76.0%[215]. Assets and Investments - Total current assets as of April 30, 2023, were $1.734 billion, an increase from $1.520 billion as of January 29, 2023, indicating a growth of approximately 14.1%[195]. - Total assets increased to $2.738 billion as of April 30, 2023, up from $2.515 billion as of January 29, 2023, representing an increase of approximately 8.9%[195]. - The Company had no outstanding borrowings under the ABL Credit Facility as of April 30, 2023, maintaining a borrowing capacity of $749.6 million[188]. - The Company recorded interest income of $8.878 million for the 13 weeks ended April 30, 2023, compared to $256,000 for the same period in 2022, marking a significant increase[207]. - The estimated purchase price for an acquisition was $43.281 million, with cash and cash equivalents acquired amounting to $2.881 million[210]. Strategic Focus and Operational Changes - The company is focused on margin expansion across its consumables, healthcare, and specialty businesses, contributing to gross profit growth[147]. - The company continues to adapt its logistics and supply chain processes in response to evolving macroeconomic conditions, including rising inflation and interest rates[249]. - The company emphasizes the importance of considering adjusted EBITDA and adjusted EBITDA margin alongside other financial performance measures[254]. - Adjusted Net Income and Adjusted Basic and Diluted Earnings per Share were highlighted as key metrics for performance evaluation[255]. Internal Controls and Compliance - There were no material changes in internal control over financial reporting during the thirteen weeks ended April 30, 2023[158]. - The Company granted 8,895 restricted stock units (RSUs) with a weighted-average grant-date fair value of $35.21 during the 13 weeks ended April 30, 2023[220]. - As of April 30, 2023, total unrecognized compensation expense related to unvested RSUs was $626.0 million, expected to be recognized over a weighted-average period of 3.1 years[222].
Chewy(CHWY) - 2022 Q4 - Earnings Call Transcript
2023-03-23 00:28
Chewy, Inc. (NYSE:CHWY) Q4 2022 Results Conference Call March 22, 2023 5:00 PM ET Company Participants Bob LaFleur - Vice President, Investor Relations Sumit Singh - Chief Executive Officer Mario Marte - Chief Financial Officer Conference Call Participants Nat Schindler - Bank of America Anna Andreeva - Needham Jian Li - Evercore ISI Doug Anmuth - JPMorgan Corey Grady - Jefferies Seth Basham - Wedbush Brian Fitzgerald - Wells Fargo Lauren Schenk - Morgan Stanley Operator Good afternoon. Thank you for attend ...
Chewy(CHWY) - 2023 Q4 - Annual Report
2023-03-21 16:00
10 Our ability to improve margins and maintain profitability will also depend on the factors described above. We cannot provide assurance that we will be able to successfully manage any of the foregoing challenges to our future growth. Any of these factors could cause our net sales growth to decline and may adversely affect our margins and profitability. We have also benefited from increasing pet ownership and discretionary spending on pets. To the extent these trends slow or reverse, our net sales, margins ...
Chewy(CHWY) - 2022 Q3 - Earnings Call Transcript
2022-12-09 02:31
Chewy, Inc. (NYSE:CHWY) Q3 2022 Earnings Conference Call December 8, 2022 5:00 PM ET Company Participants Robert LaFleur - Vice President, Investor Relations Sumit Singh - Chief Executive Officer Mario Marte - Chief Financial Officer Conference Call Participants Doug Anmuth - JPMorgan Mark Mahaney - Evercore Anna Andreeva - Needham & Company Brian Fitzgerald - Wells Fargo Corey Grady - Jefferies Lee Horowitz - Deutsche Bank Eric Sheridan - Goldman Sachs Dylan Carden - William Blair Justin Kleber - Baird Chr ...
Chewy(CHWY) - 2023 Q3 - Quarterly Report
2022-12-07 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Class A Common Stock, par value $0.01 per share CHWY New York Stock Exchange FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SE ...
Chewy(CHWY) - 2022 Q2 - Earnings Call Transcript
2022-08-30 22:47
Chewy, Inc. (NYSE:CHWY) Q2 2022 Earnings Conference Call August 30, 2022 5:00 PM ET Company Participants Robert LaFleur - Vice President, Investor Relations Sumit Singh - Chief Executive Officer Mario Marte - Chief Financial Officer Conference Call Participants Corey Tarlowe - Jefferies Brian Fitzgerald - Wells Fargo Doug Anmuth - JPMorgan Lauren Schenk - Morgan Stanley Anna Andreeva - Needham Dylan Carden - William Blair Eric Sheridan - Goldman Sachs Deepak Mathivanan - Wolfe Research Justin Kleber - Baird ...
Chewy(CHWY) - 2023 Q2 - Quarterly Report
2022-08-29 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to ____ Commission File Number: 001-38936 CHEWY, INC. (Exact name of registrant as specified in its charter) Delaware 90-1020167 (State or other jurisdict ...
Chewy(CHWY) - 2022 Q1 - Earnings Call Transcript
2022-06-02 00:12
Chewy, Inc. (NYSE:CHWY) Q1 2022 Results Conference Call June 1, 2022 5:00 PM ET Company Participants Robert LaFleur - VP, IR Sumit Singh - CEO Mario Marte - CFO Conference Call Participants Mark Mahaney - Evercore Doug Anmuth - JPMorgan Nat Schindler - Bank of America Brian Fitzgerald - Wells Fargo Steph Wissink - Jefferies Dylan Carden - William Blair Lauren Schenk - Morgan Stanley Deepak Mathivanan - Wolfe Research Justin Kleber - Baird Operator Good afternoon. Thank you for attending today's Chewy's Q1 F ...
Chewy(CHWY) - 2023 Q1 - Quarterly Report
2022-05-31 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 1, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to ____ Commission File Number: 001-38936 CHEWY, INC. (Exact name of registrant as specified in its charter) Delaware 90-1020167 (State or other jurisdictio ...
Chewy(CHWY) - 2021 Q4 - Earnings Call Transcript
2022-03-30 00:44
Chewy, Inc. (NYSE:CHWY) Q4 2021 Results Conference Call March 29, 2022 5:00 PM ET Company Participants Robert LaFleur - VP, IR Sumit Singh - CEO Mario Marte - CFO Conference Call Participants Brian Fitzgerald - Wells Fargo Deepak Mathivanan - Wolfe Research Lauren Schenk - Morgan Stanley Mark Mahaney - ISI Stephanie Wissink - Jefferies Doug Anmuth - JPMorgan Matt Norton - Guggenheim Operator Good afternoon. Thank you for attending today's Chewy's Q4 Fiscal Year 2021 Earnings Call. My name is Bethany, and I ...